SIC 5122
Wholesale-Drugs, Proprietaries & Druggists' Sundries
11 companies · 3 with disclosed financials
Total revenue (latest)
$583.64B
Total net income
—
Avg net margin
—
Median net margin
—
5-year industry trend
Total revenue summed across 1 companies in the most recent fiscal year. Median margin is the cross-sectional median per year.
Largest by revenue
- 1MCKMCKESSON CORP
$92.09B cap · as of 2025-12-31
$307.13B
revenue
- 2CAHCARDINAL HEALTH INC
$47.22B cap · as of 2026-03-31
$190.58B
revenue
- 3CORCencora, Inc.
$53.49B cap · as of 2025-12-31
$85.93B
revenue
- 4ZSTKZeroStack Corp.
$10.4M cap
—
revenue
- 5HLFHERBALIFE LTD.
$1.29B cap
—
revenue
- 6WGRXWellgistics Health, Inc.
$10.4M cap
—
revenue
- 7HWHHWH International Inc.
$7.9M cap
—
revenue
- 8STEKStemtech Corp
$23.2K cap
—
revenue
- 9NASCCan B Corp
—
revenue
- 10COSMCosmos Health Inc.
$13.7M cap
—
revenue
- 11NUSNU SKIN ENTERPRISES, INC.
$287.9M cap
—
revenue
Insider activity in this industry · last 12 months
Insider buying
$151.6M
Insider selling
$152.0M
Net flow
−$388.6K
Distinct insiders
35
Open-market trades summed across all 4 companies in the industry where insiders bought. Sales counted across all companies regardless. Filed via SEC Form 4.
Recently filed in this industry
Related industries
About the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry on ActaClear
ActaClear tracks 11 US-listed public companies classified under SEC SIC code 5122 (Wholesale-Drugs, Proprietaries & Druggists' Sundries). Combined latest-period revenue across the sector is $583.64B,
Every name on this page links to a full company dashboard with 5-year SEC financials, live market data, ratios, AI-summarised business description, insider transactions, and institutional ownership. Data is sourced directly from SEC EDGAR XBRL filings and refreshed continuously.